Role of Mentosoothe Compound in the Management of Attention Deficit Hyperactivity Disorder
Phase 2
- Conditions
- Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type
- Registration Number
- CTRI/2023/07/055683
- Lead Sponsor
- ational Institute of Ayurveda Jaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1Children of either sex in between age group of 5 to 10 years.
2Known case of ADHD.
3Children with average/normal IQ
4Subjects satisfying DSM-5 criteria of diagnosis
Exclusion Criteria
•Children with any critical mental disease.
•Children with known gross physical disability.
•Children with any known genetic disorder and congenital disorder.
•Children with any associated long term or fatal disease.
•Children with known systemic disorder like Diabetes Mellitus, Nephrotic syndrome etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method